Research progress on anti-inflammatory mechanism of blood-activating and stasis-resolving traditional Chinese medicine
CHENG Fang1 HU Kunmin1 ZHU Shan2
1.Medical College of Pediatrics, Henan University of Chinese Medicine, Henan Province, Zhengzhou 450000, China;
2.Department of Pediatrics, the Second Affiliated Hospital of Henan University of Chinese Medicine, Henan Province, Zhengzhou 450000, China
Abstract:Blood-activating and stasis-resolving traditional Chinese medicines are mainly used for blood stasis syndrome of the pain of internal medicine, amenorrhoea, dysmenorrhea, traumatic injury, sore and ulcer, swelling, and so on. Inflammation is the natural response of the body to various injury stimuli. Blood-activating and stasis-resolving traditional Chinese medicine has certain advantages in inhibiting inflammatory reaction. This paper analyzes the anti-inflammatory mechanism of nine traditional Chinese medicines including Corydalis Rhizoma, Chuanxiong Rhizoma, Salviae Miltiorrhizae Radix Et Rhizoma, Curcumae Radix, Olibanum, Leonuri Herba, Achyranthis Bidentatae Radix, Strychni Semen, and Hirudo by searching the literature. It is found that blood-activating and stasis-resolving traditional Chinese medicine mainly plays an anti-inflammatory role by three signal pathways of nuclear factor- κB, mitogen-activated protein kinase, nuclear transcription factor E2 related factor 2-antioxidant response element. It also provides research direction for the existing problems in this research field, and provides reliable theoretical basis for further exploring the anti-inflammatory component target and clinical application of blood-activating and stasis-resolving traditional Chinese medicines.
程芳1 胡坤敏1 朱珊2. 活血化瘀类中药抗炎机制研究进展[J]. 中国医药导报, 2023, 20(8): 46-49,65.
CHENG Fang1 HU Kunmin1 ZHU Shan2. Research progress on anti-inflammatory mechanism of blood-activating and stasis-resolving traditional Chinese medicine. 中国医药导报, 2023, 20(8): 46-49,65.
[1] 孙正骥,吴露,张伟.基于炎症反应探讨活血化瘀法防治动脉粥样硬化的策略[J].中西医结合心脑血管病杂志,2020,18(18):3012-3016.
[2] 万盈盈,张宏,张春艳,等.基于关联规则和复杂系统熵聚类的活血化瘀法治疗膝骨关节炎的用药规律研究[J].世界中西医结合杂志,2021,16(1):29-33.
[3] 王靖怡,李军,陈恒文,等.冠心病血瘀证免疫炎症机制研究撷要[J].世界科学技术-中医药现代化,2020,22(11):3803-3809.
[4] 殷智宇,阮文晴,孙龙,等.去氢紫堇碱对慢性炎性痛小鼠痛行为学及脊髓炎症因子表达的影响[J].中国医药导报,2021,18(2):4-7,11.
[5] 程连芝,周家梅,马俊龙,等.延胡索乙素通过抑制p38 MAPK信号通路介导的小胶质细胞活化改善糖尿病大鼠神经病理性疼痛[J].中国中药杂志,2022,47(9):2533- 2540.
[6] Wen B,Dang Y,Wu SH,et al. Antiatherosclerotic effect of dehydrocorydaline on ApoE-/- mice:inhibition of macrophage inflammation [J]. Acta Pharmacol Sin,2021,9(22):1-11.
[7] Kong XP,Chen ZC,Xia YJ,et al. Dehydrocorydaline accounts the majority of anti-inflammatory property of Corydalis Rhizoma in cultured macrophage [J]. Evid Based Complement Alternat Med,2020,2020:4181696.
[8] 马宁宁,范姗姗,李欣,等.川芎的抗炎物质筛选及其作用机制分析[J].中国实验方剂学杂志,2018,24(18):140- 146.
[9] Liu ZK,Ng CF,Shiu HT,et al. A traditional Chinese formula composed of Chuanxiong Rhizoma and Gastrodiae Rhizoma (Da Chuanxiong Formula) suppresses inflammatory response in LPS-induced RAW 264.7 cells through inhibition of NF-κB pathway [J]. J Ethnopharmacol,2017,196:20- 28.
[10] Ye T,Li Y,Xiong D,et al. Combination of Danshen and ligustrazine has dual anti-inflammatory effect on macro- phages and endothelial cells [J]. J Ethnopharmacol,2021, 266:113425.
[11] 邬爽,侯冉冉,李秋,等.丹参地上部分丹酚酸A的抗炎活性及对p38MAPK通路的影响[J].黑龙江畜牧兽医,2020(8):119-123,150.
[12] 张海云,韩伟东,刘海梅,等.丹参酮ⅡA对急性肺损伤小鼠炎症因子和氧化应激水平的影响[J].解剖学研究,2020,42(6):491-495.
[13] Xie Q,Li F,Fang L,et al. The antitumor efficacy of β-elemene by changing tumor inflammatory environment and tumor microenvironment [J]. Biomed Res Int,2020, 2020:6892961.
[14] 夏耀宗,施绍瑞,胡伟,等.β-榄香烯对肺炎克雷伯菌致急性肺炎大鼠的保护作用[J].广东药科大学学报,2021, 37(6):19-25.
[15] Li YH,Liu JW,Wu YC,et al. Guaiane-type sesquiterpenes from Curcumawenyujin [J]. Phytochemistry,2022,198:113164.
[16] 唐丽清,覃琴,冯柏林,等.桂郁金醇提物含药血清对过氧化氢诱导的人脐静脉内皮细胞损伤的保护作用[J].中药材,2019,42(11):2651-2657.
[17] B?觟rner F,Werner M,Ertelt J,et al. Analysis of boswellic acid contents and related pharmacological activities of frankincense-based remedies that modulate inflammation [J]. Pharmaceuticals(Basel),2021,14(7):660.
[18] 梁东蕊,宋志前,宁张弛,等.乳香与醋乳香对溃疡性结肠炎大鼠抗炎作用的对比研究[J].世界科学技术-中医药现代化,2020,22(1):101-107.
[19] 赵子樟,李佳晌,宿树兰,等.基于网络药理学及细胞实验的乳香-没药功效成分抗炎机制研究[J].中国中药杂志,2021,46(21):5674-5682.
[20] Chen C,Zhu Z,Hu N,et al. Leonurine hydrochloride suppresses inflammatory responses and ameliorates cartilage degradation in osteoarthritis via NF-κB signaling pathway [J]. Inflammation,2020,43(1):146-154.
[21] 胡志良,池豪,丁水印.益母草碱预处理对大鼠缺氧/复氧心肌细胞存活能力及TLR4/NF-κB通路蛋白表达的影响[J].郑州大学学报(医学版),2021,56(4):521- 525.
[22] Cheng C,Zhang W,Zhang C,et al. Hyperoside ameliorates DSS-induced colitis through MKRN1-mediated regulation of PPARγ signaling and Th17/Treg balance [J]. J Agric Food Chem,2021,69(50):15240-15251.
[23] 马笃军,华树良,彭力平,等.牛膝醇提物对实验兔膝骨关节炎模型AMPK/Wnt/MAPK信号通路串话的影响[J].中医药导报,2021,27(7):16-21,26.
[24] Ge X,Wang Y,Yu S,et al. Anti-inflammatory activity of a poly peptide fraction from achyranthes bidentate in amyloid β oligomers induced model of Alzheimer's disease [J]. Front Pharmacol,2021,12:716177.
[25] Cheng Q,Shen Y,Cheng Z,et al. Achyranthes bidentata polypeptide k suppresses neuroinflammation in BV2 microglia through Nrf2-dependent mechanism [J]. Ann Transl Med,2019,7(20):575.
[26] Yang Y,Gu Y,Zhao H,et al. Loganin attenuates osteoarthritis in rats by inhibiting IL-1β-induced catabolism and apoptosis in chondrocytes via regulation of phosphatidylinositol 3-kinases (PI3K)/Akt [J]. Med Sci Monit,2019, 25:4159-4168.
[27] Cheng YC,Chiu YM,Dai ZK,et al. Loganin ameliorates painful diabetic neuropathy by modulating oxidative stress,inflammation and insulin sensitivity in streptozotocin- nicotinamide-induced diabetic rats [J]. Cells,2021,10(10):2688.
[28] Zhang J,Wang C,Kang K,et al. Loganin attenuates septic acute renal injury with the participation of AKT and Nrf2/HO-1 signaling pathways [J]. Drug Des Devel Ther,2021,15:501-513.
[29] Han JR,Pang XX,Zhang YG,et al. Hirudin protects against kidney damage in streptozotocin-induced diabetic nephropathy rats by inhibiting inflammation via P38 MAPK/NF-κB pathway [J]. Drug Des Devel Ther,2020, 14:3223-3234.
[30] Peng L,Pan X,Yin G. Natural hirudin increases rat flap viability by anti-inflammation via PARs/p38/NF-κB pathway [J]. Biomed Res Int,2015,2015:597264.
[31] Lu J,Chen X,Xu X,et al. Active polypeptides from Hirudo inhibit endothelial cell inflammation and macrophage foam cell formation by regulating the LOX-1/LXR-α/ABCA1 pathway [J]. Biomed Pharmacother,2019,115:108840.
[32] Du J,Kang Z,Huang L,et al. Protective effects of Hirudin against compartment syndrome in rabbits through the activation of Nrf2/HO-1 [J]. Injury,2022,53(2):408-415.